Copyright
©The Author(s) 2015.
World J Transplant. Dec 24, 2015; 5(4): 338-347
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.338
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.338
Table 4 Graft survival censored by recipient death with a functioning graft at different periods after kidney transplant
| Time | Everolimus (n = 59) | Azathioprine/MMF (n = 114) |
| Year 1 | 100% | 97% |
| Year 2 | 100% | 94% |
| Year 3 | 98% | 93% |
| Year 4 | 96% | 88% |
| Year 5 | 96% | 88% |
| Year 6 | 93% | 83% |
- Citation: González F, Valjalo R. Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful. World J Transplant 2015; 5(4): 338-347
- URL: https://www.wjgnet.com/2220-3230/full/v5/i4/338.htm
- DOI: https://dx.doi.org/10.5500/wjt.v5.i4.338